CD274 and gastric cancer: To date, PD-1/PD-L1 combination therapy has demonstrated robust clinical efficacy in managing various cancers, including non-small cell lung cancer, colorectal cancer, gastric cancer, breast cancer, and liver cancer, where it can work synergistically with radiotherapy, chemotherapy, and targeted treatments to combat tumours.